Metropolitan Life Insurance Company (MetLife)’s Genesco GCO Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio GCO Stock Details GCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-673	Closed	-$18.9K	–	836
2024 Q1	$18.9K	Hold	673	–	–	﹤0.01%	1886
2023 Q4	$23.7K	Hold	673	–	–	﹤0.01%	1840
2023 Q3	$20.7K	Hold	673	–	–	﹤0.01%	1880
2023 Q2	$16.9K	Hold	673	–	–	﹤0.01%	2019
2023 Q1	$24.8K	Sell	673 -136	-17%	-$5.96K	﹤0.01%	1769
2022 Q4	$37.2K	Hold	809	–	–	﹤0.01%	1652
2022 Q3	$31.8K	Hold	809	–	–	﹤0.01%	1761
2022 Q2	$40.4K	Hold	809	–	–	﹤0.01%	1634
2022 Q1	$51.5K	Sell	809 -3,012	-79%	-$196K	﹤0.01%	1576
2021 Q4	$245K	Hold	3,821	–	–	﹤0.01%	1880
2021 Q3	$221K	Hold	3,821	–	–	﹤0.01%	1996
2021 Q2	$243K	Sell	3,821 -848	-18%	-$46K	﹤0.01%	2006
2021 Q1	$222K	Sell	4,669 -329	-7%	-$14.1K	﹤0.01%	1945
2020 Q4	$150K	Hold	4,998	–	–	﹤0.01%	2132
2020 Q3	$108K	Hold	4,998	–	–	﹤0.01%	2171
2020 Q2	$108K	Hold	4,998	–	–	﹤0.01%	2208
2020 Q1	$66.7K	Hold	4,998	–	–	﹤0.01%	2275
2019 Q4	$240K	Sell	4,998 -382	-7%	-$15.8K	﹤0.01%	1788
2019 Q3	$215K	Sell	5,380 -1,309	-20%	-$50.5K	﹤0.01%	1827
2019 Q2	$283K	Hold	6,689	–	–	﹤0.01%	1661
2019 Q1	$305K	Hold	6,689	–	–	0.01%	1620
2018 Q4	$296K	Hold	6,689	–	–	0.01%	1555
2018 Q3	$315K	Hold	6,689	–	–	0.01%	1691
2018 Q2	$266K	Hold	6,689	–	–	﹤0.01%	1755
2018 Q1	$272K	Hold	6,689	–	–	﹤0.01%	1690
2017 Q4	$217K	Sell	6,689 -6,208	-48%	-$171K	﹤0.01%	1865
2017 Q3	$343K	Hold	12,897	–	–	﹤0.01%	1934
2017 Q2	$437K	Sell	12,897 -1,927	-13%	-$86K	﹤0.01%	1799
2017 Q1	$822K	Hold	14,824	–	–	0.01%	1332
2016 Q4	$921K	Sell	14,824 -436	-3%	-$26.6K	0.01%	1342
2016 Q3	$831K	Hold	15,260	–	–	0.01%	1388
2016 Q2	$981K	Sell	15,260 -644	-4%	-$42.6K	0.01%	1264
2016 Q1	$1.15M	Sell	15,904 -1,244	-7%	-$80.3K	0.01%	1108
2015 Q4	$975K	Hold	17,148	–	–	0.01%	1205
2015 Q3	$979K	Sell	17,148 -483	-3%	-$30K	0.01%	1200
2015 Q2	$1.16M	Sell	17,631 -865	-5%	-$59.3K	0.01%	1192
2015 Q1	$1.32M	Hold	18,496	–	–	0.01%	1057
2014 Q4	$1.42M	Hold	18,496	–	–	0.01%	1120
2014 Q3	$1.38M	Buy	18,496 +272	+1%	+$21.7K	0.01%	1095
2014 Q2	$1.5M	Sell	18,224 -1,823	-9%	-$139K	0.01%	1117
2014 Q1	$1.5M	Hold	20,047	–	–	0.01%	1109
2013 Q4	$1.47M	Buy	20,047 +1,412	+8%	+$98.6K	0.01%	1111
2013 Q3	$1.22M	Buy	18,635 +188	+1%	+$12.9K	0.01%	1169
2013 Q2	$1.24M	Buy	+18,447	New	+$1.19M	0.01%	1122

Other funds holding GCO

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s GCO Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Genesco (GCO) in Q2 2024, closing a stake of 673 shares — an estimated $18.9K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in GCO in Q2 2013 and held it in 44 quarters. The position peaked at $1.5M in Q2 2014. 114 funds tracked by Wall St. Rank hold GCO as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Genesco position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 673 Genesco shares in Q2 2024, an estimated $18.9K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Genesco in Q2 2013 and held it in 44 quarters.
Metropolitan Life Insurance Company (MetLife)'s Genesco position peaked at $1.5M in Q2 2014.
114 funds tracked by Wall St. Rank held Genesco as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.